In detail, blocking IL-10 led to a significant reduction in parasite burden in a study on S. mansoni reinfection [66], while targeting GITR with an agonist anti-GITR antibody presented no effect on parasite levels or IFN-γ production in visceral leishmaniasis. This evidence concerns the gene TNFRSF18 and visceral leishmaniasis.